Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of pyridine hydrochloride cas 628-13-7 in China. Welcome to wholesale bulk high quality pyridine hydrochloride cas 628-13-7 for sale here from our factory. Good service and reasonable price are available.
Pyridine hydrochloride, also known as pyridinium chloride, is a chemical compound. It exists as a white to brownish crystalline solid and is hygroscopic in nature. This compound has a melting point range of 145-147°C and a boiling point of 222-224°C. It is soluble in water, with a solubility of 85 g/100 mL, and it is also soluble in ethanol, appearing as a clear, colorless to light yellow solution.
In terms of its applications, it serves as an important intermediate in organic synthesis and pharmaceutical production. It is used in the manufacturing of methyl erythromycin and other chemicals. Additionally, it finds use in biochemical research and as a reactive agent in unsaturated polyurethane rubber vulcanization.
The production typically involves reacting pyridine with hydrochloric acid under controlled conditions. The resulting compound is then purified and packaged for various industrial and research purposes.
|
|
|
| Chemical Formula | C5H6ClN |
| Exact Mass | 115.02 |
| Molecular Weight | 115.56 |
| m/z | 115.02 (100.0%), 117.02 (32.0%), 116.02 (5.4%), 118.02 (1.7%) |
| Elemental Analysis | C, 51.97; H, 5.23; Cl, 30.68; N, 12.12 |
Application in Methyl Erythromycin Production
Serving as a crucial intermediate in the synthesis of methyl erythromycin. Methyl erythromycin, a novel broad-spectrum antibiotic, is particularly effective in treating infectious diseases through oral administration. Its specific chemical properties and reactivity make it an ideal starting material for this synthesis.
The production of methyl erythromycin from pyridine hydrochloride involves complex chemical reactions. Typically, which undergoes a series of transformations, including substitution, condensation, and other reactions, to yield the final antibiotic product. The specific synthetic pathway may vary depending on the manufacturing process and conditions.
As an important pharmaceutical intermediate, it contributes to the production of methyl erythromycin, which has significant therapeutic value in the medical field. Methyl erythromycin is widely used to treat a variety of infections, including respiratory infections, skin infections, and other bacterial infections.
About Methyl erythromycin
Methyl erythromycin, also known as Clarithromycin, is a type of macrolide antibiotic derived from erythromycin. It exists as a white or off-white crystalline powder, odorless but with a bitter taste. This antibiotic is readily soluble in chloroform, slightly soluble in acetone, and sparingly soluble in methanol, ethanol, and ether, while it is insoluble in water.
Clarithromycin is primarily used to treat various infections, including upper and lower respiratory tract infections and subcutaneous tissue infections. As a macrolide antibiotic, it shares a similar mechanism of action and antibacterial spectrum with erythromycin. However, it demonstrates enhanced antibacterial activity against certain bacteria, such as Streptococcus pyogenes, Staphylococcus aureus (methicillin-sensitive), Neisseria species, and anaerobes. Additionally, it is highly effective against Chlamydia trachomatis and Mycoplasma pneumoniae.
The recommended dosage for adults is 400 mg per day, taken in two divided doses, while for children, it is 10 to 15 mg/kg per day, administered in two to three divided doses. Adjustments to the dosage can be made based on age and symptoms.
In summary, Clarithromycin, or methyl erythromycin, is a potent macrolide antibiotic with broad-spectrum antibacterial activity. Its specific antibacterial properties and effective dosage make it a valuable treatment option for a range of infections. However, it should be used cautiously in pregnant women, children, and individuals with severely impaired liver or kidney function.
Experimental Case
Pyridine hydrochloride, a well-known chemical compound, has been extensively studied in various experimental contexts. One notable case involves its potential use in male contraception and sterilization.
In a specific study, indenopyridine hydrochloride (IH), a derivative of pyridine, was evaluated for its ability to inhibit spermatogenesis in male rats and dogs. The rats were administered a single oral dose of IH ranging from 60mg to 200mg per kilogram of body weight. The results were striking: within 9 hours of administration, a significant increase in apoptotic germ cells was observed in the seminiferous tubules. By 48 hours, almost all seminiferous tubules contained apoptotic cells. Furthermore, long-term histopathology examination revealed that the rats in the 100mg and 200mg per kg groups remained infertile six months after treatment.
When the same dosage was applied to male dogs, a significant reduction in total sperm count and viability was noted, accompanied by an increase in sperm deformity. The spermatogenesis index (SI) dropped to 2.53±0.16, indicating male infertility.
Moreover, IH demonstrated antitumor activity against germ cell-derived tumor cells (JKT-1 cells). Using an MTT-based cytotoxicity assay, it was found that IH suppressed the growth of these tumor cells.
This study underscores the potential of derivatives, such as IH, in developing male contraceptives, sterilization agents, and treatments for germ cell-derived tumors. The compound's specificity towards the male reproductive system, with minimal toxicity to other organs, makes it a promising candidate for further research and development.
In conclusion, the experimental research has not only expanded our understanding of its biological effects but has also paved the way for potential new applications in human and animal health. As research continues, we may see the emergence of innovative treatments and contraceptives based on this versatile chemical compound.
Considering its broad range of applications, the future research directions for pyridine hydrochloride in these areas are equally diverse and promising.
In organic synthesis and pharmaceutical production, the focus will likely be on optimizing its use as an intermediate to enhance the efficiency and yield of target compounds. Researchers may also explore new synthetic pathways that incorporate it, expanding its potential use in the production of novel pharmaceuticals and chemicals.
In the manufacturing of methyl erythromycin and other chemicals, further research could aim to improve the purity and consistency of the derived products, ensuring their safety and effectiveness for medical use.
In biochemical research, whose role as a reactive agent and its potential interactions with biological molecules will continue to be investigated. Understanding these interactions could lead to new insights into cellular processes and disease mechanisms, paving the way for the development of novel therapeutic strategies.
In engineering, the potential uses could span a wide range of industries, including electronics, aerospace, and automotive. In electronics, for instance, it could be used in the development of new conductive materials or in the fabrication of electronic devices with improved performance. In aerospace and automotive applications, pyridine hydrochloride-based materials could be used to enhance the durability, corrosion resistance, or lightweight properties of components.
Lastly, in the field of unsaturated polyurethane rubber vulcanization, researchers may explore the use as a reactive agent to improve the physical properties of rubber products, such as durability and elasticity.
Industry Background and Market Demand Drivers
Hydrochloric acid pyridine, as the hydrochloride form of pyridine, possesses both the basicity of the pyridine ring and the stability of hydrochloric acid, and is widely used in the fields of medicine, pesticides, organic synthesis, and functional materials. Its core demand is driven by the following factors:
The demand for pharmaceutical intermediates is increasing
Hydrochloric acid pyridine is a key intermediate for synthesizing anti-tuberculosis drugs (such as isoniazid), antiviral drugs (such as ritonavir), and vitamin B6 derivatives. With the resurgence of tuberculosis cases worldwide (as per WHO statistics, the number of new cases exceeded 10 million in 2023) and the acceleration of antiviral drug research and development, its demand is expected to grow at an average annual rate of 5% - 8%. Additionally, the widespread use of vitamin B6 (hydrochloride pyridoxine) in dietary supplements and chronic disease treatments further drives the demand for raw materials.
Structural upgrading in the pesticide industry
Hydrochloric acid pyridine can be used to synthesize new herbicides (such as pyridine carboxylic acids) and insecticides (such as imidacloprid). The global pesticide market is transitioning from high-toxicity organophosphorus compounds to low-toxicity, high-efficiency varieties. The proportion of pyridine-based pesticides has increased from 12% in 2020 to 18% in 2025, providing additional growth space for hydrochloric acid pyridine.
Expansion in organic synthesis and new materials fields
As a catalyst and ligand, hydrochloric acid pyridine performs well in asymmetric synthesis and the preparation of metal-organic framework materials (MOFs). For example, it participates in the catalytic synthesis of chiral amines, with a yield of over 90%, meeting the pharmaceutical industry's demand for high-purity chiral molecules. Moreover, research on the application of hydrochloric acid pyridine in lithium-ion battery electrolyte additives and conductive polymer materials is gradually being industrialized.
Technological Progress and Cost Optimization
Process improvement
The traditional method of directly forming salts from pyridine and hydrogen chloride gas has issues of low yield (about 75%) and high energy consumption. In recent years, ionic liquid catalysis and microchannel reactor technology have been introduced, reducing the reaction time by 50%, increasing the yield to 92%, and reducing chlorine gas emissions by 30%. For instance, after adopting a continuous flow process, a certain enterprise expanded its single-line production capacity from 500 tons per year to 2,000 tons per year, with a cost reduction of 40%.
Green chemistry trend driving
Biocatalytic synthesis of hydrochloric acid pyridine has become a research hotspot. In 2024, a research team from the Chinese Academy of Sciences used engineered yeast strains to synthesize pyridine alcohol from glucose and then hydrochlorinate it to obtain hydrochloric acid pyridine, with a total yield of 65%, an increase of 15 percentage points compared to the chemical method, and without heavy metal pollution. If this technology is industrialized, it may disrupt the traditional production pattern.
Regional Markets and Competitive Landscape
Asia-Pacific region dominates demand
China and India, with their cost advantages and well-developed chemical industry chains, occupy 65% of the global hydrochloric acid pyridine market. China's production capacity is concentrated in regions such as Shandong and Jiangsu, with leading enterprises (such as a certain chemical group) having an annual production capacity of 15,000 tons, accounting for 40% of the domestic market. India attracts multinational pharmaceutical companies with its low labor costs (only one-third of China's), and its export volume has grown at an average annual rate of 12%.
Europe and the United States focus on high-end applications
European and American companies (such as BASF and Dow Chemical) focus on the production of high-purity hydrochloric acid pyridine (purity ≥ 99.5%) for semiconductor-grade chemicals and pharmaceutical intermediates. In 2025, the global market for high-purity products is expected to reach 230 million US dollars, with a compound annual growth rate of 9%, higher than that of ordinary products (5%).
Challenges and Risks
Strict environmental regulations
Hydrochloric acid pyridine production involves chlorine gas emissions and the treatment of salt-containing wastewater. China's "Chemical Synthesis Pharmaceutical Industry Water Pollutant Discharge Standards" require that the concentration of chloride in wastewater be ≤ 800 mg/L. Enterprises need to invest tens of millions of yuan to build membrane separation or evaporation crystallization devices, and small and medium-sized enterprises face the pressure of elimination.
Fluctuations in raw material prices
Pyridine accounts for 60% - 70% of the cost of hydrochloric acid pyridine, and its price is significantly affected by oil prices and coal chemical production capacity. In 2024, due to geopolitical conflicts, the price of pyridine rose from 12,000 yuan per ton to 18,000 yuan per ton, compressing the gross profit margin of hydrochloric acid pyridine to 15% - 20%.
Future Development Trends
Vertical integration of the industry chain
Leading enterprises are shifting from single intermediate production to an integrated layout of "pyridine - hydrochloric acid pyridine - downstream preparations". For instance, a certain group has built a pyridine base production base in Shandong, equipped with lines for hydrochloric acid pyridine and isoniazid production, reducing costs by 25% compared to decentralized procurement.
Emerging markets are rising
The pharmaceutical and pesticide markets in Southeast Asia and Latin America are growing rapidly, with projected annual growth rates of 10% from 2025 to 2030. Chinese enterprises have established factories in Vietnam and Brazil, taking advantage of local tax incentives and free trade agreements to expand their market share.
Technological innovation drives
New technologies such as photocatalysis and electrochemical synthesis may break through the bottlenecks of traditional processes. In 2025, Japanese scientists developed a visible light-driven pyridine chlorination reaction that can be completed at room temperature, reducing energy consumption by 90%. If implemented on a large scale, it will reshape the industry landscape.
Conclusion: Under the impetus of the growth in pharmaceutical and pesticide demand and technological upgrades, the market size of the hydrochloric acid pyridine industry is expected to expand at a compound annual growth rate of 6% - 8% in the next five years. Enterprises need to focus on the research and development of green processes, breakthroughs in high-end products, and global layout to cope with environmental pressure and cost fluctuations and seize the opportunities in emerging markets.
Hot Tags: pyridine hydrochloride cas 628-13-7, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, Phenol red powder, 4 4 5 5 tetramethyl 2 triphenylen 2 yl 1 3 2 dioxaborolane, 1 Butanesulfonic acid 1 1 2 2 3 3 4 4 4 nonafluoro benzo b naphtho 1 2 d furan 2 yl ester, CAS 125552 59 2, 2 12 12 dimethyl 12 H spiro cyclohexane 1 6 indeno 1 2 b fluorene 3 yl 4 4 5 5 tetramethyl 1 3 2 dioxaborolane, CAS 213 46 7